Kieffer Tara Lynn (CIK 1834835) reported 5 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-13). Recent activity: Buy ENTA (1,575 shares), Buy ENTA (4,987 shares), Sell ENTA (3,257 shares), Sell ENTA (2,106 shares), Sell ENTA (753 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-13 | ENANTA PHARMACEUTICALS INC (ENTA) | Chief Product Strategy Officer | Buy | 1,575 | $0 |
| 2026-02-13 | ENANTA PHARMACEUTICALS INC (ENTA) | Chief Product Strategy Officer | Buy | 4,987 | $0 |
| 2026-02-13 | ENANTA PHARMACEUTICALS INC (ENTA) | Chief Product Strategy Officer | Sell | 3,257 | $46,412 |
| 2025-12-05 | ENANTA PHARMACEUTICALS INC (ENTA) | Chief Product Strategy Officer | Sell | 2,106 | $29,968 |
| 2025-12-03 | ENANTA PHARMACEUTICALS INC (ENTA) | Chief Product Strategy Officer | Sell | 753 | $10,632 |
Source: SEC Form 4 filings · as of 2026-02-13